{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "OtherAbstract": [], "SpaceFlightMission": [], "InvestigatorList": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "PMID": "39090085", "DateCompleted": {"Year": "2024", "Month": "08", "Day": "01"}, "DateRevised": {"Year": "2024", "Month": "08", "Day": "04"}, "Article": {"Language": ["eng"], "ELocationID": ["6477", "10.1038/s41467-024-50642-0"], "ArticleDate": [{"Year": "2024", "Month": "08", "Day": "01"}], "Journal": {"ISSN": "2041-1723", "JournalIssue": {"Volume": "15", "Issue": "1", "PubDate": {"Year": "2024", "Month": "Aug", "Day": "01"}}, "Title": "Nature communications", "ISOAbbreviation": "Nat Commun"}, "ArticleTitle": "Dual-site molecular glues for enhancing protein-protein interactions of the CDK12-DDB1 complex.", "Pagination": {"StartPage": "6477", "MedlinePgn": "6477"}, "Abstract": {"AbstractText": ["Protein-protein interactions (PPIs) stabilization with molecular glues plays a crucial role in drug discovery, albeit with significant challenges. In this study, we propose a dual-site approach, targeting the PPI region and its dynamic surroundings. We conduct molecular dynamics simulations to identify critical sites on the PPI that stabilize the cyclin-dependent kinase 12 - DNA damage-binding protein 1 (CDK12-DDB1) complex, resulting in\u00a0further cyclin K degradation. This exploration leads to the creation of LL-K12-18, a dual-site molecular glue, which enhances the glue properties to augment degradation kinetics and efficiency. Notably, LL-K12-18 demonstrates strong inhibition of gene transcription and anti-proliferative effects in tumor cells, showing significant potency improvements in MDA-MB-231 (88-fold) and MDA-MB-468 cells (307-fold) when compared to its precursor compound SR-4835. These findings underscore the potential of dual-site approaches in disrupting CDK12 function and offer a structural insight-based framework for the design of cyclin K molecular glues."], "CopyrightInformation": "\u00a9 2024. The Author(s)."}, "AuthorList": [{"Identifier": ["0009-0005-3119-7509"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The School of Pharmacy, Fujian Medical University, Fuzhou, China."}], "LastName": "Zhang", "ForeName": "Zemin", "Initials": "Z"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing, China."}, {"Identifier": [], "Affiliation": "State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China."}], "LastName": "Li", "ForeName": "Yuanqing", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Key Laboratory of Microbial Pathogenesis and Interventions of Fujian Province University, the Key Laboratory of Innate Immune Biology of Fujian Province, Biomedical Research Center of South China, College of Life Sciences, Fujian Normal University, Fuzhou, China."}], "LastName": "Yang", "ForeName": "Jie", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China."}], "LastName": "Li", "ForeName": "Jiacheng", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The School of Pharmacy, Fujian Medical University, Fuzhou, China."}], "LastName": "Lin", "ForeName": "Xiongqiang", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The School of Pharmacy, Fujian Medical University, Fuzhou, China."}], "LastName": "Liu", "ForeName": "Ting", "Initials": "T"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Key Laboratory of Microbial Pathogenesis and Interventions of Fujian Province University, the Key Laboratory of Innate Immune Biology of Fujian Province, Biomedical Research Center of South China, College of Life Sciences, Fujian Normal University, Fuzhou, China."}], "LastName": "Yang", "ForeName": "Shiling", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The School of Pharmacy, Fujian Medical University, Fuzhou, China."}], "LastName": "Lin", "ForeName": "Jin", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing, China."}, {"Identifier": [], "Affiliation": "State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China."}], "LastName": "Xue", "ForeName": "Shengyu", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing, China."}, {"Identifier": [], "Affiliation": "State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China."}], "LastName": "Yu", "ForeName": "Jiamin", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing, China."}, {"Identifier": [], "Affiliation": "State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China."}], "LastName": "Tang", "ForeName": "Cailing", "Initials": "C"}, {"Identifier": ["0009-0007-8121-368X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China."}, {"Identifier": [], "Affiliation": "University of Chinese Academy of Sciences, Beijing, China."}], "LastName": "Li", "ForeName": "Ziteng", "Initials": "Z"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Zhongshan Institute for Drug Discovery, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Zhongshan, China."}], "LastName": "Liu", "ForeName": "Liping", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmaceutical Science and Technology, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Hangzhou, China."}], "LastName": "Ye", "ForeName": "Zhengzheng", "Initials": "Z"}, {"Identifier": ["0000-0002-1383-4368"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmaceutical Science and Technology, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Hangzhou, China."}], "LastName": "Deng", "ForeName": "Yanan", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmaceutical Science and Technology, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Hangzhou, China."}], "LastName": "Li", "ForeName": "Zhihai", "Initials": "Z"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing, China."}, {"Identifier": [], "Affiliation": "State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China."}, {"Identifier": [], "Affiliation": "University of Chinese Academy of Sciences, Beijing, China."}], "LastName": "Chen", "ForeName": "Kaixian", "Initials": "K"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China. hding@simm.ac.cn."}, {"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, School of Pharmacy, Guizhou Medical University, Guiyang, China. hding@simm.ac.cn."}], "LastName": "Ding", "ForeName": "Hong", "Initials": "H"}, {"Identifier": ["0000-0003-3864-8382"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The School of Pharmacy, Fujian Medical University, Fuzhou, China. cluo@simm.ac.cn."}, {"Identifier": [], "Affiliation": "State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China. cluo@simm.ac.cn."}, {"Identifier": [], "Affiliation": "Zhongshan Institute for Drug Discovery, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Zhongshan, China. cluo@simm.ac.cn."}, {"Identifier": [], "Affiliation": "School of Pharmaceutical Science and Technology, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Hangzhou, China. cluo@simm.ac.cn."}, {"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, School of Pharmacy, Guizhou Medical University, Guiyang, China. cluo@simm.ac.cn."}], "LastName": "Luo", "ForeName": "Cheng", "Initials": "C"}, {"Identifier": ["0000-0002-0840-6553"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China. hlin@fjnu.edu.cn."}, {"Identifier": [], "Affiliation": "Key Laboratory of Microbial Pathogenesis and Interventions of Fujian Province University, the Key Laboratory of Innate Immune Biology of Fujian Province, Biomedical Research Center of South China, College of Life Sciences, Fujian Normal University, Fuzhou, China. hlin@fjnu.edu.cn."}, {"Identifier": [], "Affiliation": "Zhongshan Institute for Drug Discovery, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Zhongshan, China. hlin@fjnu.edu.cn."}], "LastName": "Lin", "ForeName": "Hua", "Initials": "H"}], "GrantList": [{"GrantID": "22377013", "Agency": "National Natural Science Foundation of China (National Science Foundation of China)", "Country": ""}, {"GrantID": "2021J01203", "Agency": "Natural Science Foundation of Fujian Province (Fujian Provincial Natural Science Foundation)", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Nat Commun", "NlmUniqueID": "101528555", "ISSNLinking": "2041-1723"}, "ChemicalList": [{"RegistryNumber": "EC 2.7.11.22", "NameOfSubstance": "CDK12 protein, human"}, {"RegistryNumber": "EC 2.7.11.22", "NameOfSubstance": "Cyclin-Dependent Kinases"}, {"RegistryNumber": "0", "NameOfSubstance": "DNA-Binding Proteins"}, {"RegistryNumber": "0", "NameOfSubstance": "CCNK protein, human"}, {"RegistryNumber": "0", "NameOfSubstance": "Cyclins"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["metabolism"], "DescriptorName": "Cyclin-Dependent Kinases"}, {"QualifierName": [], "DescriptorName": "Cell Line, Tumor"}, {"QualifierName": [], "DescriptorName": "Protein Binding"}, {"QualifierName": [], "DescriptorName": "Molecular Dynamics Simulation"}, {"QualifierName": ["metabolism", "chemistry"], "DescriptorName": "DNA-Binding Proteins"}, {"QualifierName": [], "DescriptorName": "Cell Proliferation"}, {"QualifierName": [], "DescriptorName": "Cyclins"}], "CoiStatement": "The authors declare no competing interests."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Zhang, Q. C. et al. Structure-based prediction of protein\u2013protein interactions on a genome-wide scale. Nature490, 556\u2013560 (2012). 10.1038/nature11503", "ArticleIdList": ["10.1038/nature11503", "PMC3482288", "23023127"]}, {"Citation": "Kim, M. et al. A protein interaction landscape of breast cancer. Science374, eabf3066 (2021). 10.1126/science.abf3066", "ArticleIdList": ["10.1126/science.abf3066", "PMC9040556", "34591612"]}, {"Citation": "Garlick, J. M. & Mapp, A. K. Selective modulation of dynamic protein complexes. Cell Chem. Biol.27, 986\u2013997 (2020). 10.1016/j.chembiol.2020.07.019", "ArticleIdList": ["10.1016/j.chembiol.2020.07.019", "PMC7469457", "32783965"]}, {"Citation": "Dewey, J. A. et al. Molecular glue discovery: current and future approaches. J. Med. Chem.66, 9278\u20139296 (2023). 10.1021/acs.jmedchem.3c00449", "ArticleIdList": ["10.1021/acs.jmedchem.3c00449", "PMC10805529", "37437222"]}, {"Citation": "Xue, Y., Bolinger, A. A. & Zhou, J. Novel approaches to targeted protein degradation technologies in drug discovery. Expert Opin. Drug Discov.18, 467\u2013483 (2023). 10.1080/17460441.2023.2187777", "ArticleIdList": ["10.1080/17460441.2023.2187777", "PMC11089573", "36895136"]}, {"Citation": "Kathleen et al. Protacs: chimeric molecules that target proteins to the Skp1\u2013Cullin\u2013F box complex for ubiquitination and degradation. Proc. Natl Acad. Sci.98, 8554\u20138559 (2001). 10.1073/pnas.141230798", "ArticleIdList": ["10.1073/pnas.141230798", "PMC37474", "11438690"]}, {"Citation": "B\u00e9k\u00e9s, M., Langley, D. R. & Crews, C. M. PROTAC targeted protein degraders: the past is prologue. Nat. Rev. Drug Discov.21, 181\u2013200 (2022). 10.1038/s41573-021-00371-6", "ArticleIdList": ["10.1038/s41573-021-00371-6", "PMC8765495", "35042991"]}, {"Citation": "Burslem, G. M. & Crews, C. M. Proteolysis-targeting chimeras as therapeutics and tools for biological discovery. Cell181, 102\u2013114 (2020). 10.1016/j.cell.2019.11.031", "ArticleIdList": ["10.1016/j.cell.2019.11.031", "PMC7319047", "31955850"]}, {"Citation": "Schreiber, S. L. The rise of molecular glues. Cell184, 3\u20139 (2021). 10.1016/j.cell.2020.12.020", "ArticleIdList": ["10.1016/j.cell.2020.12.020", "33417864"]}, {"Citation": "Tinworth, C. P. & Young, R. J. Facts, patterns, and principles in drug discovery: appraising the rule of 5 with measured physicochemical data. J. Med. Chem.63, 10091\u201310108 (2020). 10.1021/acs.jmedchem.9b01596", "ArticleIdList": ["10.1021/acs.jmedchem.9b01596", "32324397"]}, {"Citation": "Kozicka, Z. & Thom\u00e4, N. H. Haven\u2019t got a glue: protein surface variation for the design of molecular glue degraders. Cell Chem. Biol.28, 1032\u20131047 (2021). 10.1016/j.chembiol.2021.04.009", "ArticleIdList": ["10.1016/j.chembiol.2021.04.009", "33930325"]}, {"Citation": "Luh, L. M. et al. Prey for the proteasome: targeted protein degradation\u2014a medicinal chemist\u2019s perspective. Angew. Chem. Int. Ed.59, 15448\u201315466 (2020).10.1002/anie.202004310", "ArticleIdList": ["10.1002/anie.202004310", "PMC7496094", "32428344"]}, {"Citation": "Kong, N. R. & Jones, L. H. Clinical translation of targeted protein degraders. Clin. Pharm. Ther.114, 558\u2013568 (2023).10.1002/cpt.2985", "ArticleIdList": ["10.1002/cpt.2985", "37399310"]}, {"Citation": "Wu, H. et al. Molecular glues modulate protein functions by inducing protein aggregation: a promising therapeutic strategy of small molecules for disease treatment. Acta Pharm. Sin. B12, 3548\u20133566 (2022). 10.1016/j.apsb.2022.03.019", "ArticleIdList": ["10.1016/j.apsb.2022.03.019", "PMC9513498", "36176907"]}, {"Citation": "Dong, G., Ding, Y., He, S. & Sheng, C. Molecular glues for targeted protein degradation: from serendipity to rational discovery. J. Med. Chem.64, 10606\u201310620 (2021). 10.1021/acs.jmedchem.1c00895", "ArticleIdList": ["10.1021/acs.jmedchem.1c00895", "34319094"]}, {"Citation": "Ito, T. et al. Identification of a primary target of thalidomide teratogenicity. Science327, 1345\u20131350 (2010). 10.1126/science.1177319", "ArticleIdList": ["10.1126/science.1177319", "20223979"]}, {"Citation": "Narla, A. E. et al. Lenalidomide causes selective degradation of IKZF1 and IKZF3 in multiple myeloma cells. Science343, 301\u2013305 (2014). 10.1126/science.1244851", "ArticleIdList": ["10.1126/science.1244851", "PMC4077049", "24292625"]}, {"Citation": "Lu, G. et al. The myeloma drug lenalidomide promotes the cereblon-dependent destruction of Ikaros proteins. Science343, 305\u2013309 (2014). 10.1126/science.1244917", "ArticleIdList": ["10.1126/science.1244917", "PMC4070318", "24292623"]}, {"Citation": "Fischer, E. S. et al. Structure of the DDB1\u2013CRBN E3 ubiquitin ligase in complex with thalidomide. Nature512, 49\u201353 (2014). 10.1038/nature13527", "ArticleIdList": ["10.1038/nature13527", "PMC4423819", "25043012"]}, {"Citation": "Kr\u00f6nke, J. et al. Lenalidomide induces ubiquitination and degradation of CK1\u03b1 in del (5q) MDS. Nature523, 183\u2013188 (2015). 10.1038/nature14610", "ArticleIdList": ["10.1038/nature14610", "PMC4853910", "26131937"]}, {"Citation": "Matyskiela, M. E. et al. A novel cereblon modulator recruits GSPT1 to the CRL4CRBN ubiquitin ligase. Nature535, 252\u2013257 (2016). 10.1038/nature18611", "ArticleIdList": ["10.1038/nature18611", "27338790"]}, {"Citation": "Han, T. et al. Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15. Science356, eaal3755 (2017). 10.1126/science.aal3755", "ArticleIdList": ["10.1126/science.aal3755", "28302793"]}, {"Citation": "Slabicki, M. et al. The CDK inhibitor CR8 acts as a molecular glue degrader that depletes cyclin K. Nature585, 293\u2013297 (2020). 10.1038/s41586-020-2374-x", "ArticleIdList": ["10.1038/s41586-020-2374-x", "PMC7486275", "32494016"]}, {"Citation": "Dieter, S. M. et al. Degradation of CCNK/CDK12 is a druggable vulnerability of colorectal cancer. Cell Rep.36, 109394 (2021). 10.1016/j.celrep.2021.109394", "ArticleIdList": ["10.1016/j.celrep.2021.109394", "34289372"]}, {"Citation": "Quereda, V. et al. Therapeutic targeting of CDK12/CDK13 in triple-negative breast cancer. Cancer Cell36, 545\u2013558 (2019). 10.1016/j.ccell.2019.09.004", "ArticleIdList": ["10.1016/j.ccell.2019.09.004", "31668947"]}, {"Citation": "Lv, L. et al. Discovery of a molecular glue promoting CDK12-DDB1 interaction to trigger cyclin K degradation. Elife9, e59994 (2020). 10.7554/eLife.59994", "ArticleIdList": ["10.7554/eLife.59994", "PMC7462607", "32804079"]}, {"Citation": "Jorda, R. et al. 3,5,7-Substituted pyrazolo[4,3-d]pyrimidine inhibitors of cyclin-dependent kinases and cyclin K degraders. J. Med. Chem.65, 8881\u20138896 (2022). 10.1021/acs.jmedchem.1c02184", "ArticleIdList": ["10.1021/acs.jmedchem.1c02184", "35749742"]}, {"Citation": "Rehman, A. U. et al. Computational approaches for the design of modulators targeting protein-protein interactions. Expert Opin. Drug Discov.18, 315\u2013333 (2023). 10.1080/17460441.2023.2171396", "ArticleIdList": ["10.1080/17460441.2023.2171396", "PMC10149343", "36715303"]}, {"Citation": "Zhang, H. et al. Dynamics of post-translational modification inspires drug design in the kinase family. J. Med. Chem.64, 15111\u201315125 (2021). 10.1021/acs.jmedchem.1c01076", "ArticleIdList": ["10.1021/acs.jmedchem.1c01076", "34668699"]}, {"Citation": "Zhang, Y. et al. Structural basis of ketamine action on human NMDA receptors. Nature596, 301\u2013305 (2021). 10.1038/s41586-021-03769-9", "ArticleIdList": ["10.1038/s41586-021-03769-9", "34321660"]}, {"Citation": "Sun, Z. et al. Covalent inhibitors allosterically block the activation of Rho family proteins and suppress cancer cell invasion. Adv. Sci.7, 2000098 (2020).10.1002/advs.202000098", "ArticleIdList": ["10.1002/advs.202000098", "PMC7375240", "32714746"]}, {"Citation": "Rui, H., Ashton, K. S., Min, J., Wang, C. & Potts, P. R. Protein\u2013protein interfaces in molecular glue-induced ternary complexes: classification, characterization, and prediction. RSC Chem. Biol.4, 192\u2013215 (2023). 10.1039/D2CB00207H", "ArticleIdList": ["10.1039/D2CB00207H", "PMC9994104", "36908699"]}, {"Citation": "Kozicka, Z. et al. Design principles for cyclin K molecular glue degraders. Nat. Chem. Biol.20, 93\u2013102 (2024). 10.1038/s41589-023-01409-z", "ArticleIdList": ["10.1038/s41589-023-01409-z", "PMC10746543", "37679459"]}, {"Citation": "Jiang, W., Jiang, Y., Luo, Y., Qiao, W. & Yang, T. Facilitating the development of molecular glues: opportunities from serendipity and rational design. Eur. J. Med. Chem.263, 115950 (2024). 10.1016/j.ejmech.2023.115950", "ArticleIdList": ["10.1016/j.ejmech.2023.115950", "37984298"]}, {"Citation": "Li, J. et al. Discovery of small-molecule degraders of the CDK9-cyclin T1 complex for targeting transcriptional addiction in prostate cancer. J. Med. Chem.65, 11034\u201311057 (2022). 10.1021/acs.jmedchem.2c00257", "ArticleIdList": ["10.1021/acs.jmedchem.2c00257", "35925880"]}, {"Citation": "Wang, M. et al. Discovery of LL-K8-22: a selective, durable, and small-molecule degrader of the CDK8-cyclin C complex. J. Med. Chem.66, 4932\u20134951 (2023). 10.1021/acs.jmedchem.2c02045", "ArticleIdList": ["10.1021/acs.jmedchem.2c02045", "36930701"]}, {"Citation": "Lin, R. et al. Discovery of HyT\u2010based degraders of CDK9\u2010cyclin T1 complex. Chem. Biodivers.20, e202300769 (2023). 10.1002/cbdv.202300769", "ArticleIdList": ["10.1002/cbdv.202300769", "37349855"]}, {"Citation": "Brinda, K. V. & Vishveshwara, S. A network representation of protein structures: implications for protein stability. Biophys. J.89, 4159\u20134170 (2005). 10.1529/biophysj.105.064485", "ArticleIdList": ["10.1529/biophysj.105.064485", "PMC1366981", "16150969"]}, {"Citation": "Slabicki, M. et al. Small-molecule-induced polymerization triggers degradation of BCL6. Nature588, 164\u2013168 (2020). 10.1038/s41586-020-2925-1", "ArticleIdList": ["10.1038/s41586-020-2925-1", "PMC7816212", "33208943"]}, {"Citation": "Sinko, W., Lindert, S. & McCammon, J. A. Accounting for receptor flexibility and enhanced sampling methods in computer\u2010aided drug design. Chem. Biol. Drug Des.81, 41\u201349 (2013). 10.1111/cbdd.12051", "ArticleIdList": ["10.1111/cbdd.12051", "PMC3540989", "23253130"]}, {"Citation": "Antunes, D. A., Devaurs, D. & Kavraki, L. E. Understanding the challenges of protein flexibility in drug design. Expert Opin. Drug Discov.10, 1301\u20131313 (2015). 10.1517/17460441.2015.1094458", "ArticleIdList": ["10.1517/17460441.2015.1094458", "26414598"]}, {"Citation": "Thomas, K. L. et al. Degradation by design: new cyclin k degraders from old CDK inhibitors. ACS Chem. Biol.19, 173\u2013184 (2024). 10.1021/acschembio.3c00616", "ArticleIdList": ["10.1021/acschembio.3c00616", "PMC10804372", "38193430"]}, {"Citation": "Akhtar, M. S. et al. TFIIH kinase places bivalent marks on the carboxy-terminal domain of RNA polymerase II. Mol. Cell34, 387\u2013393 (2009). 10.1016/j.molcel.2009.04.016", "ArticleIdList": ["10.1016/j.molcel.2009.04.016", "PMC2757088", "19450536"]}, {"Citation": "Blazek, D. et al. The cyclin K/CDK12 complex maintains genomic stability via regulation of expression of DNA damage response genes. Genes Dev.25, 2158\u20132172 (2011). 10.1101/gad.16962311", "ArticleIdList": ["10.1101/gad.16962311", "PMC3205586", "22012619"]}, {"Citation": "Johannes, J. W. et al. Structure-based design of selective noncovalent CDK12 inhibitors. ChemMedChem13, 231\u2013235 (2018). 10.1002/cmdc.201700695", "ArticleIdList": ["10.1002/cmdc.201700695", "29266803"]}, {"Citation": "Le Guilloux, V., Schmidtke, P. & Tuffery, P. Fpocket: an open source platform for ligand pocket detection. BMC Bioinform.10, 168 (2009).10.1186/1471-2105-10-168", "ArticleIdList": ["10.1186/1471-2105-10-168", "PMC2700099", "19486540"]}, {"Citation": "Seeber, M., Cecchini, M., Rao, F., Settanni, G. & Caflisch, A. Wordom: a program for efficient analysis of molecular dynamics simulations. Bioinformatics23, 2625\u20132627 (2007). 10.1093/bioinformatics/btm378", "ArticleIdList": ["10.1093/bioinformatics/btm378", "17717034"]}, {"Citation": "Ma, J. et al. iProX: an integrated proteome resource. Nucleic Acids Res.47, D1211\u2013D1217 (2019). 10.1093/nar/gky869", "ArticleIdList": ["10.1093/nar/gky869", "PMC6323926", "30252093"]}, {"Citation": "Chen, T. et al. iProX in 2021: connecting proteomics data sharing with big data. Nucleic Acids Res.50, D1522\u2013D1527 (2022). 10.1093/nar/gkab1081", "ArticleIdList": ["10.1093/nar/gkab1081", "PMC8728291", "34871441"]}]}], "History": [{"Year": "2024", "Month": "1", "Day": "6"}, {"Year": "2024", "Month": "7", "Day": "18"}, {"Year": "2024", "Month": "8", "Day": "2", "Hour": "0", "Minute": "47"}, {"Year": "2024", "Month": "8", "Day": "2", "Hour": "0", "Minute": "46"}, {"Year": "2024", "Month": "8", "Day": "1", "Hour": "23", "Minute": "14"}, {"Year": "2024", "Month": "8", "Day": "1"}], "PublicationStatus": "epublish", "ArticleIdList": ["39090085", "PMC11294606", "10.1038/s41467-024-50642-0", "10.1038/s41467-024-50642-0"]}}]}